Interchangeability of Haemophilus influenzae type b vaccines in the primary series: Evaluation of a two-dose mixed regimen

Pediatrics

Volumn 98, Issue 5, 1996, Pages 898-904

  Bewley, Kathleen M ^a   Schwab, Joel G ^a   Ballanco, Gerard A ^b   Daum, Robert S ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

conjugate vaccines; Haemophilus influenzae type b vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ANTIBODY TITER; AREA UNDER THE CURVE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ERYTHEMA; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFANT; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0029907848     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. American Academy of Pediatrics, Committee on Infectious Diseases. Report of the Committee on Infectious Disease. Haemophilus influenzae type b. Chicago, IL: American Academy of Pediatrics; 1994: 203-216
2. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1994;43(RR-1):1-38
3. Goldstein KP, Kviz FJ, Daum RS. Predictive value of immunization histories provided by adults accompanying pre-school children to a pediatric emergency room. JAMA. 1993;270:2190-2194
4. Goldstein KP, Glushak C, Kviz FJ, et al. Assessment of immunization rates of inner-city children. Pediatr Res. 1994;35:114A. Abstract 667
5. Daum RS, Granoff DM. Lessons from the evaluation of immunogenicity. In: Ellis RW, Granoff DM, eds. Development and Clinical Uses of Haemophilus b Conjugate Vaccines. New York, NY: Marcel Dekker, Inc; 1994:291-312
6. Einhorn MS, Weinberg GA, Anderson EL, Granoff PD, Granoff DM. Immunogenicity in infants of H. influenzae type b polysaccharide in a conjugate vaccine with Neisseria meningitidis outer membrane protein complex conjugate vaccine. Lancet. 1986;2:299-302
7. Daum RS, Siber GR, Ballanco GA, Sood SK. Serum antibody response in the first week after immunization with the H influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Infect Dis. 1991;64:1154-1159
8. Ambrosino DM, Sood SK, Lee MC, et al. IgG1, IgG2 and IgM responses to two H. influenzae type b conjugate vaccines in young infants. Pediatr Infect Dis J. 1992;11:855-859
9. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care. 1994; 17:152-154
10. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 1992;20:184-189
11. Eskola J, Kayhty H, Gordon LK, et al. Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated polio vaccinations of childhood. Pediatr Infect Dis J. 1988;7: 480-484
12. Eskola J, Kayhty H, Takala A. Protective efficacy of the HbOC and PRP-D Haemophilus influenzae type b conjugate vaccines when given at 4,6, and 14 to 18 months of age. Pediatr Res. 1990;27:179A. Abstract 1056
13. Eskola J, Kayhty H, Takala A, et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against Haemophilus influenzae type b disease. N Engl J Med. 1990;323:1381-1387
14. Harrison LH, Tajkowski C, Croll J, et al. Postlicensure effectiveness of the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine among Navajo children. J Pediatr. 1994;125:571-578
15. Greenberg DP, Vadheim CM, Partidge S, Chang SJ, Chiu CY, Ward JI. Post-licensure evaluation of PRP-OMP lots with less than expected immunogenicity. Pediatr Res. 1993;33:169A. Abstract 996
16. Egan W, Frasch CE, Anthony BF. Lot-release criteria, postlicensure quality control, and the Haemophilus influenzae type b conjugate vaccines. JAMA. 1995;273:888-889
17. Granoff DM, Anderson EL, Osterholm MT, et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr. 1992;121:184-189
18. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of H. influenzae type b. J Infect Dis. 1984;149:1034
19. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med. 1991;324:1767-1772
20. Anderson EL, Decker MD, Englund JA, et al. Interchangeably of conjugated Haemophilus influenzae type b vaccines in infants. JAMA. 1995;273:849-853
21. Greenberg DP, Chiu CY, Ward JI. Enhanced antibody responses in infants given different sequences of heterogenous Haemophilus influenzae type b conjugate vaccines. J Pediatr. 1995;126:206-211
22. Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis. 1993;168:663-671
23. Anderson P, Pichichero M, Edwards K, Porch CR, Insel R. Priming and induction of Haemophilus influenzae type b capsular antibodies by Dpo20, an oligosaccharide-protein conjugate vaccine. J Pediatr. 1987;111: 644-650
24. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with a Haemophilus influenzae type b conjugate vaccine. J Infect Dis. 1991;164:982-986
25. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children immunized with Haemophilus influenzae type b conjugate vaccine. J Pediatr. 1993;22:517-523